Free Trial

Inari Medical Q1 2024 Earnings Report

Inari Medical logo
$56.16 -0.59 (-1.04%)
(As of 12/17/2024 ET)

Inari Medical EPS Results

Actual EPS
-$0.26
Consensus EPS
-$0.11
Beat/Miss
Missed by -$0.15
One Year Ago EPS
N/A

Inari Medical Revenue Results

Actual Revenue
$143.19 million
Expected Revenue
$138.32 million
Beat/Miss
Beat by +$4.87 million
YoY Revenue Growth
N/A

Inari Medical Announcement Details

Quarter
Q1 2024
Time
N/A

Conference Call Resources

Conference Call Audio

Slide Deck

2025 AI Stock Picks: 2 Hidden Gems Under $10/Share (Ad)

The AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.

👉[Click here to get your FREE report delivered instantly!]

Inari Medical Earnings Headlines

Inari Medical initiated with an Outperform at Oppenheimer
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.
Demystifying Inari Medical: Insights From 6 Analyst Reviews
See More Inari Medical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Inari Medical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Inari Medical and other key companies, straight to your email.

About Inari Medical

Inari Medical (NASDAQ:NARI) builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States. The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases; InThrill system to treat small vessel thrombosis; and LimFlow system for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and risk of major amputation. It serves interventional radiologists, interventional cardiologists, and vascular surgeons. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.

View Inari Medical Profile

More Earnings Resources from MarketBeat

Upcoming Earnings